BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• BioMidwest

  ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering Of Convertible Notes

  December 4, 2014

   · 

  7 min read
• Genetown

  Caldera Pharmaceuticals Announces Corporate Name Change To XRpro Sciences, Inc.

  December 4, 2014

   · 

  3 min read
• BioMidwest

  Zimmer Provides Update On The European Commission Review Process Relating To The Pending Merger With Biomet Inc.

  December 4, 2014

   · 

  8 min read
• Pharm Country

  Becton, Dickinson and Company To Offer Senior Unsecured Notes

  December 4, 2014

   · 

  2 min read
• BioMidwest

  PDL BioPharma, Inc. Announces Conversion Rate Adjustments For Convertible Notes

  December 4, 2014

   · 

  3 min read
• Deals

  Genetics Policy Institute (GPI) Release: Two Leading Stem Cell and Regenerative Medicine Advocacy Groups Announce Merger Plan

  December 4, 2014

   · 

  3 min read
• Biotech Beach

  REVA Medical Implants First Patients With Fantom Scaffold

  December 4, 2014

   · 

  4 min read
• Biotech Bay

  Adamas Pharmaceuticals Issued Six Additional U.S. Patents

  December 4, 2014

   · 

  5 min read
• Business

  Rexahn Pharmaceuticals, Inc. Appoints Richard Rodgers To Its Board Of Directors

  December 4, 2014

   · 

  3 min read
• Policy

  ChemoCentryx, Inc. Granted EU Orphan Drug Designation For CCX168, An Orally Administered Complement C5a Receptor Inhibitor, For The Treatment Of Microscopic Polyangiitis And Granulomatosis With Polyangiitis, Two Forms Of ANCA-Associated Vasculitis

  December 4, 2014

   · 

  5 min read